Arkolith/Insider Trading/ADXS/Form 4

Israel Biotech Fund GP Partners, L.P.

10% OwnerAyala Pharmaceuticals, Inc. (ADXS) · full profile →Form 4 · filed Nov 21, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
10
0 non-derivative · 10 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 17, 2023Buy(P)3.1M——15.3M
Nov 17, 2023Buy(P)3.1M——14.1M
Nov 17, 2023Buy(P)4.7M——18.5M
Nov 17, 2023Buy(P)5.6M——9.7M
Nov 17, 2023Buy(P)0——23.2M
Nov 17, 2023Buy(P)0——27.6M
Nov 17, 2023Buy(P)2.8M——6.9M
Nov 17, 2023Buy(P)6.2M——6.0M
Nov 17, 2023Buy(P)6.2M——12.2M
Nov 17, 2023Buy(P)10.3M——17.2M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001178913-23-003762) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML